Sept. 3, 2025
— Jeff Ward, Lehigh Valley News Briefs
Thermo Fisher Scientific, a maker of medical and laboratory equipment, has completed its purchase of a Sanofi drug-manufacturing plant in Ridgefield, New Jersey.
“The Ridgefield facility is now part of Thermo Fisher’s pharma services business within its Laboratory Products and Biopharma Services segment,” Thermo Fisher said in a press release.
About 200 employees at the Ridgefield plant are joining Thermo Fisher.
Terms of the purchase were not disclosed.
Thermo Fisher is based in Waltham, Massachusetts, and has operations in the Lehigh Valley.
Shares of Thermo Fisher (NYSE:TMO) were trading at $486.34 at 9:31 a.m. Wednesday.
Sanofi is a French pharmaceutical company with operations in Monroe County.
Here’s a link to the Thermo Fisher statement
and here’s a cut-and-paste version:
Sept. 2, 2025
WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced the completion of its acquisition of Sanofi’s state-of-the-art sterile fill-finish and packaging site in Ridgefield, New Jersey, marking an expansion of the companies’ strategic partnership to enable additional U.S. drug product manufacturing. The terms of the deal were not disclosed. The Ridgefield facility is now part of Thermo Fisher’s pharma services business within its Laboratory Products and Biopharma Services segment.
Under the agreement, Thermo Fisher will continue to manufacture a portfolio of therapies for Sanofi at the Ridgefield site while expanding use of the site to meet the growing demand for U.S. manufacturing capacity from pharma and biotech customers.
“We are excited to add Sanofi’s Ridgefield site to our network and welcome more than 200 highly experienced colleagues to Thermo Fisher,” said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher. “Bringing this world-class facility and team into our network strengthens our U.S. manufacturing capabilities to better support pharmaceutical and biotech customers, while positioning us for future expansion.”
Thermo Fisher operates a leading global sterile fill-finish manufacturing network and now adds Ridgefield to its U.S. sites in Greenville, North Carolina and Plainville, Massachusetts. These sites are integral to the company’s Accelerator™ Drug Development 360° CDMO and CRO solutions, transforming the pharmaceutical value chain for emerging biotech and biopharma companies to speed life-changing medicines to patients.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
Lehigh Valley News Briefs 